# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-007860
Filing Date
2022-03-01
Accepted
2022-03-01 07:20:09
Documents
101
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | pmvp-10k_20211231.htm iXBRL | 10-K | 3641077
2 | EX-10.8 | pmvp-ex108_331.htm | EX-10.8 | 56622
3 | EX-10.14 | pmvp-ex1014_338.htm | EX-10.14 | 55516
4 | EX-10.17 | pmvp-ex1017_538.htm | EX-10.17 | 277940
5 | EX-21.1 | pmvp-ex211_332.htm | EX-21.1 | 1201
6 | EX-23.1 | pmvp-ex231_918.htm | EX-23.1 | 3641
7 | EX-31.1 | pmvp-ex311_537.htm | EX-31.1 | 23934
8 | EX-31.2 | pmvp-ex312_335.htm | EX-31.2 | 23898
9 | EX-32.1 | pmvp-ex321_336.htm | EX-32.1 | 10784
10 | EX-32.2 | pmvp-ex322_337.htm | EX-32.2 | 11270
11 | GRAPHIC | gv1ubg3hw41v000005.jpg | GRAPHIC | 25205
12 | GRAPHIC | gv1ubg3hw41v000012.jpg | GRAPHIC | 79397
13 | GRAPHIC | gfifg3pi0xun000002.jpg | GRAPHIC | 36245
14 | GRAPHIC | gw0ad20d1dfx000001.jpg | GRAPHIC | 51798
15 | GRAPHIC | gv1ubg3hw41v000013.jpg | GRAPHIC | 23857
16 | GRAPHIC | g5rlbv12cydj000002.jpg | GRAPHIC | 47726
17 | GRAPHIC | gv1ubg3hw41v000002.jpg | GRAPHIC | 244044
18 | GRAPHIC | gv1ubg3hw41v000008.jpg | GRAPHIC | 52417
19 | GRAPHIC | gfifg3pi0xun000001.jpg | GRAPHIC | 42998
20 | GRAPHIC | gv1ubg3hw41v000006.jpg | GRAPHIC | 58200
21 | GRAPHIC | gv1ubg3hw41v000011.jpg | GRAPHIC | 53203
22 | GRAPHIC | gv1ubg3hw41v000014.jpg | GRAPHIC | 192262
23 | GRAPHIC | gv1ubg3hw41v000001.jpg | GRAPHIC | 244044
24 | GRAPHIC | gv1ubg3hw41v000003.jpg | GRAPHIC | 83182
25 | GRAPHIC | gv1ubg3hw41v000016.jpg | GRAPHIC | 41280
26 | GRAPHIC | gv1ubg3hw41v000007.jpg | GRAPHIC | 86352
27 | GRAPHIC | gv1ubg3hw41v000015.jpg | GRAPHIC | 163841
28 | GRAPHIC | g5rlbv12cydj000001.jpg | GRAPHIC | 19825
29 | GRAPHIC | gv1ubg3hw41v000009.jpg | GRAPHIC | 18910
30 | GRAPHIC | gv1ubg3hw41v000004.jpg | GRAPHIC | 123537
31 | GRAPHIC | gv1ubg3hw41v000010.jpg | GRAPHIC | 33984
| Complete submission text file | 0001564590-22-007860.txt |  | 15496548

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
32 | XBRL TAXONOMY EXTENSION SCHEMA | pmvp-20211231.xsd | EX-101.SCH | 59422
33 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | pmvp-20211231_cal.xml | EX-101.CAL | 53870
34 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | pmvp-20211231_def.xml | EX-101.DEF | 201438
35 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | pmvp-20211231_lab.xml | EX-101.LAB | 484828
36 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | pmvp-20211231_pre.xml | EX-101.PRE | 376654
95 | EXTRACTED XBRL INSTANCE DOCUMENT | pmvp-10k_20211231_htm.xml | XML | 1886163

Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39539 | Film No.: 22693934
SIC: 2834 Pharmaceutical Preparations